137 related articles for article (PubMed ID: 29277790)
21. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer.
Gao LB; Rao L; Wang YY; Liang WB; Li C; Xue H; Zhou B; Sun H; Li Y; Lv ML; Du XJ; Zhang L
Carcinogenesis; 2009 Feb; 30(2):295-9. PubMed ID: 19073878
[TBL] [Abstract][Full Text] [Related]
22. Association of gene and protein expression and genetic polymorphism of CC chemokine ligand 4 in colorectal cancer.
Shamoun L; Landerholm K; Balboa Ramilo A; Andersson RE; Dimberg J; Wågsäter D
World J Gastroenterol; 2021 Aug; 27(30):5076-5087. PubMed ID: 34497436
[TBL] [Abstract][Full Text] [Related]
23. Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk.
Hofmann G; Langsenlehner U; Renner W; Langsenlehner T; Yazdani-Biuki B; Clar H; Gerger A; Wehrschuetz M; Samonigg H; Krippl P
J Cancer Res Clin Oncol; 2008 May; 134(5):591-5. PubMed ID: 17938959
[TBL] [Abstract][Full Text] [Related]
24. Genetic variation in adipokine genes and risk of colorectal cancer.
Pechlivanis S; Bermejo JL; Pardini B; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
Eur J Endocrinol; 2009 Jun; 160(6):933-40. PubMed ID: 19273568
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 32 expression in human melanoma.
Paz H; Tsoi J; Kalbasi A; Grasso CS; McBride WH; Schaue D; Butterfield LH; Maurer DM; Ribas A; Graeber TG; Economou JS
J Transl Med; 2019 Apr; 17(1):113. PubMed ID: 30953519
[TBL] [Abstract][Full Text] [Related]
26. Resistin in human colorectal cancer: increased expression independently of resistin promoter -420C > G genotype.
Wågsater D; Mumtaz M; Lofgren S; Hugander A; Dimberg J
Cancer Invest; 2008 Dec; 26(10):1008-14. PubMed ID: 18798067
[TBL] [Abstract][Full Text] [Related]
27. Expression and gene polymorphisms of the chemokine CXCL5 in colorectal cancer patients.
Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
Int J Oncol; 2007 Jul; 31(1):97-102. PubMed ID: 17549409
[TBL] [Abstract][Full Text] [Related]
28. Polymorphism in MHC class II transactivator gene is not associated with susceptibility to colorectal cancer in Swedish patients.
Mumtaz M; Löfgren S; Hugander A; Dimberg J
Anticancer Res; 2008; 28(3B):1789-91. PubMed ID: 18630461
[TBL] [Abstract][Full Text] [Related]
29. EED gene polymorphism in patients with colorectal cancer.
Seo GS; Yu JI; Chae SC; Park WC; Shin SR; Yoo ST; Choi SC; Lee SH
Int J Biol Markers; 2013 Sep; 28(3):274-9. PubMed ID: 23709348
[TBL] [Abstract][Full Text] [Related]
30. Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?
Abd El-Fattah AA; Sadik NA; Shaker OG; Kamal AM
Tumour Biol; 2016 Jul; 37(7):9387-97. PubMed ID: 26779637
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
[TBL] [Abstract][Full Text] [Related]
32. Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer.
Theodoropoulos G; Papaconstantinou I; Felekouras E; Nikiteas N; Karakitsos P; Panoussopoulos D; Lazaris ACh; Patsouris E; Bramis J; Gazouli M
World J Gastroenterol; 2006 Aug; 12(31):5037-43. PubMed ID: 16937502
[TBL] [Abstract][Full Text] [Related]
33. VEGF gene polymorphisms and susceptibility to colorectal cancer.
Jannuzzi AT; Özhan G; Yanar HT; Alpertunga B
Genet Test Mol Biomarkers; 2015 Mar; 19(3):133-7. PubMed ID: 25635747
[TBL] [Abstract][Full Text] [Related]
34. The polymorphisms of osteopontin gene and plasma osteopontin protein levels with susceptibility to colorectal carcinoma.
Fan Y; Zhang X; Yang ZH; Sun XW; Li SN; Zhong L; Cheng X; Wang Y; Ma YR
DNA Cell Biol; 2013 Oct; 32(10):594-600. PubMed ID: 23952692
[TBL] [Abstract][Full Text] [Related]
35. Single nucleotide polymorphisms associated with susceptibility for development of colorectal cancer: Case-control study in a Basque population.
Alegria-Lertxundi I; Aguirre C; Bujanda L; Fernández FJ; Polo F; Ordovás JM; Etxezarraga MC; Zabalza I; Larzabal M; Portillo I; de Pancorbo MM; Palencia-Madrid L; Rocandio AM; Arroyo-Izaga M
PLoS One; 2019; 14(12):e0225779. PubMed ID: 31821333
[TBL] [Abstract][Full Text] [Related]
36. Impact of MDM2 polymorphism: increased risk of developing colorectal cancer and a poor prognosis in the Tunisian population.
Chaar I; Arfaoui TA; El Amine el HO; Mahmoud LB; Khiari M; Sammoud S; Lounis A; Amara S; Gharbi L; Hmida AB; Mzabi S; Bouraoui S
Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):320-7. PubMed ID: 22266832
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of genetic variants in miRNAs in patients with colorectal cancer.
Dikaiakos P; Gazouli M; Rizos S; Zografos G; Theodoropoulos GE
Cancer Biomark; 2015; 15(2):157-62. PubMed ID: 25519012
[TBL] [Abstract][Full Text] [Related]
38. TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer.
Proença MA; de Oliveira JG; Cadamuro AC; Succi M; Netinho JG; Goloni-Bertolo EM; Pavarino ÉC; Silva AE
World J Gastroenterol; 2015 Jul; 21(25):7730-41. PubMed ID: 26167073
[TBL] [Abstract][Full Text] [Related]
39. No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk.
Gsur A; Bernhart K; Baierl A; Feik E; Führlinger G; Hofer P; Leeb G; Mach K; Micksche M
Cancer Epidemiol; 2011 Oct; 35(5):e38-41. PubMed ID: 21612998
[TBL] [Abstract][Full Text] [Related]
40. Impact of Genetic Variation in MicroRNA-binding Site on Susceptibility to Colorectal Cancer.
Kang BW; Jeon HS; Chae YS; Lee SJ; Park JS; Choi GS; Kim JG
Anticancer Res; 2016 Jul; 36(7):3353-61. PubMed ID: 27354594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
